Patient Product Information for RotaTeq® (Rotavirus Vaccine, Live, Oral, Pentavalent)

Merck & Co., Inc. is a global research-driven pharmaceutical company dedicated to putting patients first.

Educate about rotavirus, a potentially serious and unpredictable disease.¹,²

Patient Product Information for RotaTeq

To read the Patient Product Information for RotaTeq, click below.

View Patient Product Information
(PDF: 376kb)*

Patient Education Brochure about Rotavirus

Download and print this important resource to help provide education about rotavirus.

View the Patient Education Brochure about Rotavirus
(PDF: 744kb)*

* To view PDF documents, you must have Adobe Acrobat Reader^® installed on your computer.

>	Order RotaTeq and patient materials for your practice by visiting merckvaccines.com

References
1.	Cornell SL. Confronting the consequences of rotavirus: Diarrhea and dehydration. Adv Nurse Pract. 1999;5:41–44.
2.	Santos N, Hoshino Y. Rev Med Virol. 2005;15:29–56.

Previous topic: < Ordering & Reimbursement |
Next topic: Disease Burden & Prevalence >


	Print this page	E-mail this site

This site is intended only for healthcare professionals of the United States, its territories, and Puerto Rico.
RotaTeq is a registered trademark of Merck & Co., Inc.
20750348(4)-11/07-RTQ